Literature DB >> 3005404

High efficiency gene transfer into murine T cell clones using a retroviral vector.

N Uchida, R D Cone, G J Freeman, R C Mulligan, H Cantor.   

Abstract

To establish a gene transfer and expression system for murine T cell clones, we have introduced the neomycin phosphotransferase gene encoding resistance to the neomycin analogue, G418, into non-neoplastic inducer T cell clones by using a replication-defective retroviral vector. This method allowed highly efficient gene transfer (20 to 40%) into two inducer T cell clones. The level of viral RNA expression in G418r T cells was 0.1% of poly(A)+ RNA. The infected G418r cells retained physiologic responsiveness to specific antigen as judged by antigen-specific proliferation and production of IL 3.

Entities:  

Mesh:

Year:  1986        PMID: 3005404

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Use of an Epstein-Barr virus episomal replicon for anti-sense RNA-mediated gene inhibition in a human cytotoxic T-cell clone.

Authors:  J E Hambor; C A Hauer; H K Shu; R K Groger; D R Kaplan; M L Tykocinski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

2.  Abelson virus transformation of an interleukin 2-dependent antigen-specific T-cell line.

Authors:  W D Cook; B Fazekas de St Groth; J F Miller; H R MacDonald; R Gabathuler
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

3.  Long-term expression of a T-cell receptor beta-chain gene in mice reconstituted with retrovirus-infected hematopoietic stem cells.

Authors:  J Kang; J Wither; N Hozumi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 4.  Adoptive immunotherapy for cancer or viruses.

Authors:  Marcela V Maus; Joseph A Fraietta; Bruce L Levine; Michael Kalos; Yangbing Zhao; Carl H June
Journal:  Annu Rev Immunol       Date:  2014-01-09       Impact factor: 28.527

Review 5.  Engineering lymphocyte subsets: tools, trials and tribulations.

Authors:  Carl H June; Bruce R Blazar; James L Riley
Journal:  Nat Rev Immunol       Date:  2009-10       Impact factor: 53.106

Review 6.  Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer.

Authors:  Ahmed M E Abdalla; Lin Xiao; Yu Miao; Lixia Huang; Gendeal M Fadlallah; Mario Gauthier; Chenxi Ouyang; Guang Yang
Journal:  Adv Sci (Weinh)       Date:  2020-02-20       Impact factor: 16.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.